切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2011, Vol. 05 ›› Issue (05) : 402 -405. doi: 10.3877/cma.j.issn.1674-0793.2011.05.010

所属专题: 文献

论著

桥本甲状腺炎合并甲状腺癌的临床特点
李玺1, 郭卫平2,(), 邱万寿1, 陈图峰2   
  1. 1. 510630 广州,中山大学附属第三医院甲状腺乳腺外科
    2. 510630 广州,中山大学附属第三医院胃肠外科
  • 收稿日期:2010-12-01 出版日期:2011-10-01
  • 通信作者: 郭卫平

Clinical features of Hashimoto’s thyroiditis complicated with thyroid carcinoma

Xi LI1, Wei-ping GUO2,(), Wan-shou QIU1, Tu-feng CHEN2   

  1. 1. Department of thyroid and breast surgery, the Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, China
  • Received:2010-12-01 Published:2011-10-01
  • Corresponding author: Wei-ping GUO
  • About author:
    Corresponding author: GUO Wei-ping, Email:
引用本文:

李玺, 郭卫平, 邱万寿, 陈图峰. 桥本甲状腺炎合并甲状腺癌的临床特点[J]. 中华普通外科学文献(电子版), 2011, 05(05): 402-405.

Xi LI, Wei-ping GUO, Wan-shou QIU, Tu-feng CHEN. Clinical features of Hashimoto’s thyroiditis complicated with thyroid carcinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2011, 05(05): 402-405.

目的

总结桥本甲状腺炎(HT)合并甲状腺癌的临床改变特点。

方法

收集2005年1月至2009年12月我院HT合并甲状腺癌病例24例,回顾性分析24例患者临床资料、影像学和病理改变特点。

结果

HT合并甲状腺癌病例占同期手术治疗HT患者的27.0%(24/89),高于同期未合并HT甲状腺患者中甲状腺癌的发病率(13.0%,P < 0.01),除1例滤泡状癌外余23例患者均为乳头状癌。甲状腺功能异常9例,抗甲状腺球蛋白抗体(TGAb)升高14例,甲状腺过氧化物酶抗体(TPO-Ab)升高16例。超声检查均发现甲状腺结节样病变,特征与甲状腺癌的超声影像类似,病理改变特征也与一般甲状腺癌类似。随访23例,无甲状腺癌复发及转移病例。

结论

对伴有甲状腺结节的HT患者应警惕甲状腺癌可能。其治疗措施可参照甲状腺癌的处理。

Objective

To analyze the imaging appearance and pathologic diagnosis in patients with Hashimoto’s thyroiditis (HT) complicated with thyroid carcinoma (TC) and to explore the diagnosis and surgical treatment.

Methods

The clinical and pathological data of patients with HT complicated with thyroid carcinoma were reviewed retrospectively. The preoperative US characteristics and postoperative histopathologic features in patients with and without HT were compared.

Results

The prevalence of TC in the HT patients was 27.0%. In contrast, it was 13.0% in patients without HT (P < 0.01) . The US characteristics of thyroid carcinoma were similar in the group with HT compared with the group without HT. The histopathologic characteristics of thyroid carcinoma in patients with and without HT were compared, there was no significant difference. All patients received surgical treatment. Twenty three patients underwent routine follow-up, and they had no recurrence or metastasis.

Conclusions

Nodules in patients with HT goiter need close observation of neoplastic changes because HT may predispose to the development of TC. Surgical treatment is effective for patients of HT complicated with TC is effective, and the measures of treatment may be in accordance with the principle of TC without HT.

表1 合并HT与不合并HT甲状腺癌患者超声影像特点比较[例(%)]
表2 合并HT与不合并HT甲状腺癌患者病理特点的比较[例(%)]
1
Gul,K,Dirikoc A,Kiyak G,et al. The association between thyroid carcinoma and hashimoto's thyroiditis:the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid,2010,20(8):873-878.
2
陈佳瑞,王家东. 桥本甲状腺炎合并甲状腺乳头状癌外科诊治(附51例临床分析). 临床耳鼻咽喉头颈外科杂志,2010(6):257-260.
3
Shih ML,Lee JA,Hsieh CB,et al. Thyroidectomy for Hashimoto's thyroiditis:complications and associated cancers. Thyroid,2008,18(7):729-734.
4
Larson SD,Jackson LN,Riall TS,et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg,2007,204(5):764-775.
5
Cipolla C,Sandonato L,Graceffa G,et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg,2005,71(10):874-878.
6
Sadow PM,Heinrich MC,Corless CL,et al. Absence of BRAF,NRAS,KRAS,HRAS mutations,and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. Endocr Pathol,2010,21(2):73-79.
7
潘高云,夏建克,李选峰,等,超声诊断桥本氏甲状腺炎78例分析. 中国临床医学影像杂志,2010,21(4):274-276.
8
Ohmori N,Miyakawa M,Ohmori K,et al. Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto's thyroiditis. Intern Med,2007,46(9):547-550.
9
Kebebew E,Treseler PA,Ituarte PH,et al. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg,2001,25(5):632-637.
10
Haigh PI,Urbach DR,Rotstein LE,et al. Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer. Ann Surg Oncol,2005,12(1):81-89.
11
Ito Y,Tomoda C,Uruno T,et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg,2006,30(1):91-99.
12
Montesani C,Gentili V,Pronio A,et al. Lymphadenectomy in the differentiated thyroid carcinoma. Ann Ital Chir,2004,75(3):299-303.
13
郭卫平,李玺,邱万寿,等. 预防性中央区淋巴结清扫在cN0乳头状甲状腺癌的临床价值. 中华全科医学,2010,8(10):1215-1216.
[1] 孙帼, 谢迎东, 徐超丽, 杨斌. 超声联合临床特征的列线图模型预测甲状腺乳头状癌淋巴结转移的价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 734-742.
[2] 庞嘉越成, 巨淑慧, 马冀青, 李恒宇, 盛湲. 乳腺癌易感基因突变人群接受降低乳腺癌风险手术的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 179-183.
[3] 古丽米拉·亚森江, 阿依努尔·艾尔肯, 李佳隆, 郭强, 蒋铁民, 吐尔干艾力·阿吉. 胆囊切除术后胆管损伤不同治疗方式的疗效分析[J]. 中华普通外科学文献(电子版), 2023, 17(04): 262-266.
[4] 张晓贝, 曹栋, 杨宝顺, 俞永江. 肝硬化腹水合并腹股沟疝的临床治疗进展[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 121-124.
[5] 赵佳音, 张晓萌, 张艳, 李立, 王瑞灯. 创伤后肘关节僵硬的病理机制及治疗进展[J]. 中华肩肘外科电子杂志, 2023, 11(02): 181-185.
[6] 郝壮, 马济远, 何梦梅, 李兴育, 陆新婷, 武静, 周健. 迟发性囊袋阻滞综合征临床特征、治疗方法及其疗效的临床研究[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 70-75.
[7] 钟东. 大脑凸面脑膜瘤的个体化全程管理[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 193-198.
[8] 廖环, 徐蛟天, 张海涛, 邱光庭, 蒋成昊, 陈进, 邹景芳, 张志文. 颈椎管内外节细胞神经瘤一例报道及文献复习[J]. 中华神经创伤外科电子杂志, 2023, 09(03): 186-189.
[9] 朱敏, 李法强. CD64指数联合降钙素原、白介素-6、血清淀粉样蛋白A检测对重型颅脑损伤术后颅内细菌感染的诊断价值[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 26-31.
[10] 刘家伦, 郑占乐. 跟骨载距突解剖与临床应用现状[J]. 中华老年骨科与康复电子杂志, 2023, 09(03): 188-192.
[11] 马四海, 杨剑, 马显武, 张敏, 吕明礼, 李启菊, 杨轶声, 刘海生. Shamblin Ⅱ型颈动脉体瘤的诊疗及文献综述[J]. 中华临床医师杂志(电子版), 2023, 17(04): 467-470.
[12] 赵雪琴, 苏学峰, 任东伟, 崔冰冰, 王振东, 李慧. DDX5在甲状腺癌中的表达及其临床意义[J]. 中华临床医师杂志(电子版), 2023, 17(04): 386-390.
[13] 王正宇, 孙琳. 硒联合不同药物治疗桥本甲状腺炎的研究进展[J]. 中华诊断学电子杂志, 2023, 11(02): 125-127.
[14] 江凯乐, 杨异. 肋骨骨折的手术治疗进展及存在问题[J]. 中华胸部外科电子杂志, 2023, 10(03): 149-152.
[15] 王新桥, 马超英, 张旭光. 纵隔单中心型Castleman病诊治体会及文献复习[J]. 中华胸部外科电子杂志, 2023, 10(03): 183-187.
阅读次数
全文


摘要